Tiny Perfusion Letter #147
Tiny Perfusion Letter
Since Mondays haven't been cancelled over the weekend, here's your portion of fresh perfusion literature.
10/10
Enjoy & Share
Preoperative and Intraoperative Predictive Factors of Immediate Extubation After Neonatal Cardiac Surgery.
Varghese J, Kutty S, Abdullah I, Hall S, Shostrom V, Hammel JM
Ann Thorac Surg. 2016 Nov;102(5):1588-1595
Acute Kidney Injury Severity and Long-Term Readmission and Mortality After Cardiac Surgery.
Brown JR, Hisey WM, Marshall EJ, Likosky DS, Nichols EL et al.
Ann Thorac Surg. 2016 Nov;102(5):1482-1489
Prediction of Transfusions After Isolated Coronary Artery Bypass Grafting Surgical Procedures.
Likosky DS, Paugh TA, Harrington SD, Wu X, Rogers MA et al. Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative.
Ann Thorac Surg. 2016 Oct 7. [Epub ahead of print]
The effectiveness of 10 years of interventions to control postoperative bleeding in adult cardiac surgery.
Ranucci M, Baryshnikova E, Pistuddi V, Menicanti L, Frigiola A; Surgical and Clinical Outcome REsearch (SCORE) Group.
Interact Cardiovasc Thorac Surg. 2016 Oct 17. [Epub ahead of print] FREE
Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States.
Perkins KM, Lawsin A, Hasan NA, Strong M, Halpin AL et al.
MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1117-1118 FREE
Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass.
Feng J, Sellke F
Curr Opin Cardiol. 2016 Nov;31(6):618-624
Prognostic effect of estimated glomerular filtration rate in patients with cardiogenic shock or cardiac arrest undergoing percutaneous veno-arterial extracorporeal membrane oxygenation.
Kuroki N, Abe D, Iwama T, Sugiyama K, Akashi A et al.
J Cardiol. 2016 Nov;68(5):439-446
Point-of-Care Hemostatic Testing in Cardiac Surgery: A Stepped-Wedge Clustered Randomized Controlled Trial.
Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, et al. TACS Investigators.
Circulation. 2016 Oct 18;134(16):1152-1162
Pro: The Hepcon® HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
Ural K, Owen C
J Cardiothorac Vasc Anesth. 2016 Jul 2. [Epub ahead of print]
Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
Gilly G, Trusheim J
J Cardiothorac Vasc Anesth. 2016 Aug 26. [Epub ahead of print]